A new malaria vaccine shows promising results
If further tests remain successful, it could be deployed in the field as soon as 2023
Most diseases that used to kill children in large numbers have succumbed to vaccines. Malaria is an exception. In 2020 it killed 640,000 people, mostly African children under five years old. Scientists have not ignored the scourge: the first candidate vaccine trial took place in the 1940s; more than a hundred jabs have been in development since.
This article appeared in the Science & technology section of the print edition under the headline “Parasites prevented”
From the September 10th 2022 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Science & technology
Can you breathe stress away?
It won’t hurt to try. But scientists are only beginning to understand the links between the breath and the mind
The Economist’s science and technology internship
We invite applications for the 2025 Richard Casement internship
A better understanding of Huntington’s disease brings hope
Previous research seems to have misinterpreted what is going on
Is obesity a disease?
It wasn’t. But it is now
Volunteers with Down’s syndrome could help find Alzheimer’s drugs
Those with the syndrome have more of a protein implicated in dementia
Should you start lifting weights?
You’ll stay healthier for longer if you’re strong